People with low magnesium levels in their blood after a kidney transplant are much less likely to develop diabetes afterward — in fact, their risk drops by 88%.

We analyzed the available evidence on whether low magnesium is linked to a lower risk of diabetes after a kidney transplant, and what we’ve found so far does not support that idea. There is one assertion claiming that people with low magnesium levels after transplant have an 88% lower risk of developing diabetes, but this claim is not backed by any supporting studies. Instead, 38 studies or assertions directly contradict it [1]. Our current analysis shows that the weight of the evidence leans strongly against the idea that low magnesium protects against diabetes after a kidney transplant. The single claim suggesting a benefit lacks any research foundation, while the large number of refuting reports suggests that low magnesium is not associated with reduced diabetes risk — and may even be linked to other complications. Magnesium is a mineral involved in how the body uses insulin, and low levels are often seen in people with metabolic issues. But in the context of kidney transplant patients, the evidence we’ve reviewed does not show that having less of it leads to better outcomes. Instead, the pattern across multiple reports points away from any protective effect. We don’t have enough data to say what magnesium levels are ideal after a transplant, but we can say that the idea of low magnesium lowering diabetes risk is not supported by the research we’ve seen. If you’ve had a kidney transplant and are concerned about diabetes risk, it’s best to talk with your care team about balanced nutrition and regular monitoring — not about trying to lower magnesium on purpose.